The DOI matches its Crossref record.
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation
Abstract
The prevalence of Mycobacterium tuberculosis (MTB) has increased worldwide, in part due to the HIV epidemic. Epidemiology data have demonstrated that HIV-infected individuals are more susceptible to MTB disease, which may lead to an acceleration in the progression of HIV disease. The purpose of this study was to determine whether MTB modulates HIV infection in vivo and to delineate the mechanisms involved by using in vitro model systems. Plasma viral load was measured in HIV-infected individuals before, during, and after the development of MTB disease; a 5- to 160-fold increase in viral replication was observed during the acute phase of MTB disease. In order to evaluate the mechanisms involved in this MTB-induced HIV replication, we used an in vitro system of primary PBMC and lymph node mononuclear cells isolated from HIV-infected individuals. The data demonstrated that MTB induced HIV replication in CD8+ T cell-depleted lymphocytes from HIV-infected individuals with a history of purified protein derivative (PPD) positivity but not in those who were PPD negative; this induction of HIV replication correlated with the level of cellular activation. In an in vitro acute HIV infection model, MTB increased HIV replication in PBMC from healthy donors with a history of PPD positivity, but not in PBMC from PPD-negative donors and this induction of viral replication also correlated with cellular activation. In conclusion, MTB increased HIV replication in vivo and in an in vitro model. This MTB-mediated viral production likely occurs through Ag-specific activation and infection of responding T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,461
Host factors and the pathogenesis of HIV-induced disease
Fauci, A. S. (1996) · Nature · doi:10.1038/384529a0 · Cited by 829
Self-citationTuberculosis and HIV Co-Infection
Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., & Källenius, G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002464 · Cited by 764
HIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712001 · Cited by 608
R??TTINGEN, J.-A., WILLIAM CAMERON, D., & GARNETT, G. P. (2001) · Sexually Transmitted Diseases · doi:10.1097/00007435-200110000-00005 · Cited by 540
Macrophages as a Source of HIV During Opportunistic Infections
Orenstein, J. M., Fox, C., & Wahl, S. M. (1997) · Science · doi:10.1126/science.276.5320.1857 · Cited by 525
Hepatitis C in the HIV-Infected Person
Sulkowski, M. S., & Thomas, D. L. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00012 · Cited by 405
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Bell, L. C. K., & Noursadeghi, M. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.128 · Cited by 389
Tuberculosis and HIV Coinfection: Table 1.
Bruchfeld, J., Correia-Neves, M., & Källenius, G. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017871 · Cited by 378
Target Cell Limited and Immune Control Models of HIV Infection: A Comparison
De Boer, R. J., & Perelson, A. S. (1998) · Journal of Theoretical Biology · doi:10.1006/jtbi.1997.0548 · Cited by 371
Lawn, S. D., Butera, S. T., & Folks, T. M. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.753-777.2001 · Cited by 313
Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents
Keri, R. S., B.S., S., Nagaraja, B. M., & Santos, M. A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.06.017 · Cited by 271
HIV-1/ Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?
Diedrich, C. R., & Flynn, J. L. (2011) · Infection and Immunity · doi:10.1128/iai.01126-10 · Cited by 266
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration
Hoffman, I. F., Jere, C. S., Taylor, T. E., Munthali, P., Dyer, J. R., Wirima, J. J., Rogerson, S. J., Kumwenda, N., Eron, J. J., Fiscus, S. A., et al. (1999) · Aids · doi:10.1097/00002030-199903110-00007 · Cited by 259
Mwapasa, V., Rogerson, S. J., Molyneux, M. E., Abrams, E. T., Kamwendo, D. D., Lema, V. M., Tadesse, E., Chaluluka, E., Wilson, P. E., & Meshnick, S. R. (2004) · AIDS · doi:10.1097/00002030-200404300-00014 · Cited by 142
Meyer, D. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777442164 · Cited by 34
Traoré, H. N., & Meyer, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.11.009 · Cited by 8
Metadata
- Authors
- Goletti, D., Weissman, D., Jackson, R. W., Graham, N. M., Vlahov, D., Klein, R. S., Munsiff, S. S., Ortona, L., Cauda, R., & Fauci, A. S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-08-01
- Volume
- 157
- Issue
- 3
- Pages
- 1271-1278
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2165241820
- Cited by
- 495
- References
- 0
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.